It has been postulated that people with obesity may benefit from greater metabolic reserves or an attenuated response of the renin-angiotensin-aldosterone system.8 People with obesity typically have higher arterial blood pressure, which might mean higher doses of medications are tolerated that confer a prognostic benefit in HF.8 This evidence concerns the gene REN and hydrops fetalis.